Pilot Community Clinical Study of Hypothermia in Cardiac Arrest
1 other identifier
interventional
125
0 countries
N/A
Brief Summary
The overall goal of this study is to determine the feasibility of initiating hypothermia in cardiac arrest patients as soon as possible in the field. In this pilot study we will randomize 125 patients after return of spontaneous circulation (ROSC) to hypothermia with rapid infusion of 2 liters of 4oC Normal Saline IV solution over 20 to 30 minutes, IV sedation and muscle paralysis or to standard of care following ROSC. The primary objectives of this study will be to determine whether temperature of 33-34oC can be achieved and maintained using this strategy. The primary outcome measures will include: temperature changes of the patients at time of admission to the hospital. Secondary analysis will include determining if the proportion of patients discharged from the hospital is increased in the group receiving hypothermia. If this initial pilot study can demonstrate feasibility in achieving and maintaining hypothermia, a larger randomized clinical trial to test the hypothesis that hypothermia initiation in the field will increase the proportion of patients surviving following cardiac arrest will be planned.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Nov 2004
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2006
CompletedFirst Submitted
Initial submission to the registry
May 22, 2006
CompletedFirst Posted
Study publicly available on registry
May 24, 2006
CompletedApril 17, 2017
April 1, 2017
May 22, 2006
April 13, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Temperature difference between first field temperature and hospital arrival temperature
less than 60 minutes
Secondary Outcomes (2)
Survival to discharge from hospital
Between 2 -30 days
Awakening in the hospital
between 2-30 days
Study Arms (2)
Cold fluid
EXPERIMENTALcontrol, standard of care
NO INTERVENTIONInterventions
Patients randomized to field cooling will receive up to 2 liters of 4oC normal saline. Control patients will receive standard of care following resuscitation.
Eligibility Criteria
You may qualify if:
- Resuscitated out-of-hospital cardiac arrest defined as having a palpable pulse comatose IV access Intubated
You may not qualify if:
- age less than 18 traumatic cause of cardiac arrest
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Washingtonlead
- Medic One Foundationcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Francis Kim, MD
University of Washington
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Medicine, Division of Cardiology
Study Record Dates
First Submitted
May 22, 2006
First Posted
May 24, 2006
Study Start
November 1, 2004
Study Completion
March 1, 2006
Last Updated
April 17, 2017
Record last verified: 2017-04